PROVIDER PROFILE · NPI 1013205046

Jamee TantocoMD

Allergy/ ImmunologyGlenview, ILI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

186

Unique beneficiaries

—

Total services

230

Distinct HCPCS

Medicare payment

$13K

Peer benchmark

Total Medicare services vs. 145 Allergy/ Immunology providers in IL — bottom quintile (cohort median 2,013).

PRESCRIBING · PART D · 2024

Total Rx claims

637

Beneficiaries

—

Total drug cost

$215K

Distinct drugs

Brand share

35.0%

Top prescribed drugs

Azelastine Hcl90 claims

Montelukast Sodium89 claims

Fluticasone Propionate87 claims

Albuterol Sulfate58 claims

Prednisone45 claims

QUALITY · MIPS · 2024

Final MIPS score

84.9

Quality

75.9

Cost

74.6

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

0.42%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$257

Payment records

By payment type

Food and Beverage$233

Education$23

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 140010

Hospital

REFERRAL NETWORK

Where Jamee Tantoco's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
ENDEAVOR HEALTH CLINICAL OPERATIONS	13	37

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
ENDEAVOR HEALTH CLINICAL OPERATIONS	24	97
Catherine Glunz Internal Medicine · Chicago, IL	11	20

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history